Instem (INS.L) Akcie Kurz
Instem Kurz
Tržby rostly o 14,1 % ročně za posledních 15 let na 57,63 Mil. GBP. Zisk na akcii klesal o 8,5 % ročně za posledních 15 let. čistá marže společnosti Instem je nyní 8,2 %, nahoru z 6,5 % před několika lety.
Cena akcie Instem
Tato data přes Eulerpool API
100 000 požadavků/měs. zdarma · bez karty
Obchodní model Instem a analýza akcií
Nejčastější otázky týkající se akcie Instem
The main competitors of Instem PLC in the market include companies such as LabCorp, Medidata Solutions, Oracle Health Sciences, and Parexel International.
Instem PLC is a leading provider of software solutions and services for the life sciences industry. The company primarily operates through its informatics solutions which help organizations streamline their research and development processes. Instem's software products facilitate data management, analysis, and compliance across various stages of the drug discovery and development lifecycle. By offering comprehensive solutions, Instem PLC enables organizations to improve efficiency, enhance decision-making, and accelerate time-to-market for new therapies. With a strong focus on technological innovation and domain expertise, Instem PLC continues to drive advancements in the life sciences industry.
Instem PLC is primarily active in the healthcare and life sciences industry.
Instem PLC is a leading provider of software solutions and services to the global life sciences industry. With over 30 years of experience, Instem has established itself as a trusted partner in providing innovative technology solutions for drug development, regulatory compliance, and research management. Founded in 1987, Instem has grown to become a renowned player in the life sciences space, serving over 500 customers worldwide. The company's comprehensive suite of software solutions spans the entire research lifecycle, enabling organizations to enhance productivity, streamline processes, and drive operational excellence. Instem PLC's dedication to delivering cutting-edge solutions has solidified its position as a key player in the life sciences industry.
Instem PLC has achieved several significant milestones throughout its history. The company has successfully developed and delivered innovative software solutions for the life sciences industry. Instem PLC has been recognized for its contributions to the field, winning numerous industry awards and certifications. The company has formed strategic partnerships and collaborations, expanding its global reach and customer base. Instem PLC has also demonstrated consistent financial growth, with increased revenues and profitability over the years. Additionally, the company has received positive feedback from clients, reinforcing its reputation as a leading provider of software solutions for the life sciences industry.
Instem PLC is primarily present in the United Kingdom, United States, and in several European countries. The company operates globally, providing software solutions and services for the life sciences industry. With its headquarters in the UK, Instem PLC has established a strong presence in key markets, serving clients across North America, Europe, and other parts of the world. As a leading provider of scientific data solutions, Instem PLC offers its innovative products and expertise to support research organizations, pharmaceutical companies, regulatory authorities, and contract research organizations across these regions.
Instem PLC represents a strong set of values and a robust corporate philosophy. The company is committed to delivering innovative software solutions and services to the global life sciences industry. Instem fosters a culture of integrity, excellence, and collaboration to ensure the highest level of customer satisfaction. With a focus on advancing scientific research and improving regulatory compliance, Instem aims to enhance the efficiency and effectiveness of research organizations worldwide. By consistently prioritizing customer success and embracing technologies, Instem PLC is recognized as a leading provider of solutions that drive scientific knowledge and operational excellence in the life sciences domain.
9 analytiků aktuálně hodnotí akcii Instem: 8 doporučuje koupit, 1 držet a 0 prodat.
Při aktuálním kurzu se akcie Instem obchoduje za 9,92 EUR (8,30 GBP).
Akcie Instem (INS.L) je kótována na 3 burzách, mimo jiné: London (INS.L), Frankfurt (54I.F).
Instem PLC is a UK-based company specializing in software and information solutions for the life sciences sector. The company offers a wide range of products and services aimed at supporting and accelerating research and development processes. Translation: Instem PLC is a UK-based company specializing in software and information solutions for the life sciences sector. The company offers a wide range of products and services aimed at supporting and accelerating research and development processes.
Tržby nelze pro Instem aktuálně vypočítat.
Zisk nelze pro Instem aktuálně vypočítat.
Poměr P/E nelze pro Instem aktuálně vypočítat.
Poměr P/S nelze pro Instem aktuálně vypočítat.
Score kvality pro Instem je 6/10.
ISIN Instem je GB00B3TQCK30. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.
WKN Instem je A1C7NS. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.
Ticker Instem je INS.L. Symbol tickeru se používá k obchodování akcií Instem na burze.
Instem akcie
Instem Peer Group
Instem Ticker
Instem FIGI
Všechny fundamentální údaje o Instem v podrobné analýze
Naše analýzy akcií společnosti Instem zahrnují důležité finanční ukazatele jako obrat, zisk, P/E poměr, P/S poměr, EBIT, stejně jako informace o dividendách. Dále zkoumáme aspekty jako akcie, tržní kapitalizaci, dluhy, vlastní kapitál a závazky společnosti Instem. Pokud hledáte podrobnější informace o těchto tématech, nabízíme vám na našich podstránkách rozsáhlé analýzy: